Effects of rosiglitazone/metformin fixed-dose combination therapy and metformin monotherapy on serum vaspin, adiponectin and IL-6 levels in drug-naïve patients with type 2 diabetes. (Q51388002)
Jump to navigation
Jump to search
scientific article published on 28 October 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | Effects of rosiglitazone/metformin fixed-dose combination therapy and metformin monotherapy on serum vaspin, adiponectin and IL-6 levels in drug-naïve patients with type 2 diabetes. |
scientific article published on 28 October 2010 |
Statements
Effects of rosiglitazone/metformin fixed-dose combination therapy and metformin monotherapy on serum vaspin, adiponectin and IL-6 levels in drug-naïve patients with type 2 diabetes (English)
N P E Kadoglou
H Tsanikidis
I Vitta